AIDS-Related Hodgkin Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which AIDS-Related Hodgkin Lymphoma trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

RecruitingNot Applicable

NCT00006518

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance…

BACKGROUND: * A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or other tissue samples from patients with…

United States1,029 participantsStarted 2000-12-06

RecruitingPhase 1

NCT05077527

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

This phase I trial evaluates the side effects and usefulness of axicabtagene clioleucel (a CAR-T therapy) and find out what effect, if any, it has on treating p…

United States20 participantsStarted 2025-02-13

Treatment: Axicabtagene Ciloleucel, Cyclophosphamide

RecruitingNot Applicable

NCT05663502

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Colle…

United States200 participantsStarted 2023-05-10

Treatment: Biospecimen Collection

RecruitingNot Applicable

NCT05231135

A Registry Study on HIV-related Lymphoma

Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymp…

Germany, Netherlands, Spain300 participantsStarted 2021-08-25

All recent trials (100 shown)

CompletedPhase 1

NCT00641381

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

RATIONALE: Giving high-dose chemotherapy drugs, such as carmustine, etoposide, and cyclophosphamide, before a peripheral blood stem cell transplant stops the gr…

United States25 participantsStarted 2000-05-10

Treatment: carmustine, cyclophosphamide

Active — Not RecruitingPhase 1

NCT03220022

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Tre…

This phase I trial studies the side effect and best dose of ibrutinib in combination with rituximab, etoposide, prednisone, vincristine sulfate, cyclophosphamid…

United States46 participantsStarted 2018-03-16

Treatment: Cyclophosphamide, Doxorubicin Hydrochloride

AIDS-Related Hodgkin Lymphoma

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance…

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

A Registry Study on HIV-related Lymphoma

All recent trials (100 shown)

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Tre…

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance…

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

A Registry Study on HIV-related Lymphoma

All recent trials (100 shown)

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Tre…

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudi…

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated La…

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Substituting SMSs for Provider-delivered Care to Improve Alcohol Use Outcomes

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patie…

Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Rel…

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Ho…

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies